MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Biology of Blood and Marrow Transplantation
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

605 results · 1 filter active ·
Results by year
20002020
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
605 works in the cohort · of 4,299,418page 9 of 13

Labels cover 1 of 605 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 605 of 605 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Human Stem Cells for Tissue Repair
Louisa Wirthlin, David A. Hess, Ping Zhou, Jan A. Nolta
2007· review· en· Biology of Blood and Marrow Transplantation· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
affno abstractunlabeled
Bone marrow cells for cardiac repair
Armand Keating
2005· review· en· Biology of Blood and Marrow Transplantation· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
affunlabeled
Competitive TNF Inhibitor (ETANERCEPT) for the Treatment of Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Stem Cell Transplantation (SCT). A Joint Pediatric Blood and Marrow Transplant Consortium (PBMTC) and Childrens Oncology Group (COG) Study
Gregory A. Yanik, Stephan A. Grupp, Michael A. Pulsipher, John E. Levine, Kirk R. Schultz, Donna A. Wall +4 more
2013· article· en· Biology of Blood and Marrow Transplantation· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
affunlabeled
Superior Survival After Single Unit Umbilical Cord Blood Transplantation (UCBT) in Children with Hematological Malignancies Treated on Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0501 Relative to the Cord Blood Transplantation (COBLT)
Joanne Kurtzberg, Shelly L. Carter, Adam Mendizabal, Donna A. Wall, Kirk R. Schultz, Nancy A. Kernan +2 more
2013· article· en· Biology of Blood and Marrow Transplantation· Medicine
machine prediction:candidate · noneconsensus · none
5
citations
affunlabeled
Is Any Donor Too Old?
Kirk R. Schultz
2014· letter· en· Biology of Blood and Marrow Transplantation· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Cardiac manifestations of graft-versus-host disease
Andrew L. Gilman, Cynthia Rackley, Fred Goldman, Amy Serrano, Ka Wah Chan, Kirk R. Schultz
2005· article· en· Biology of Blood and Marrow Transplantation· Medicine
machine prediction:candidate · noneconsensus · none
3
citations
affunlabeled
Targeted Conditioning with Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Leads to High Rates of Allogeneic Transplantation and Successful Engraftment in Older Patients with Active, Relapsed or Refractory (rel/ref) AML after Failure of Chemotherapy and Targeted Agents: Preliminary Midpoint Results from the Prospective, Randomized Phase 3 Sierra Trial
Boglarka Gyurkocza, Rajneesh Nath, Patrick J. Stiff, Edward Agura, Mark R. Litzow, Benjamin Tomlinson +18 more
2020· article· en· Biology of Blood and Marrow Transplantation· Medicine
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Resolution of CGD Related Colitis after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Chronic Granulomatous Disease—Early Results From the 6903 Study of the Primary Immune Deficiency Treatment Consortium (PIDTC)
Jennifer W. Leiding, Brent R. Logan, Ziyan Yin, Erin Arbuckle, Jack Bleesing, Kathleen E. Sullivan +36 more
2018· article· en· Biology of Blood and Marrow Transplantation· Immunology and Microbiology
machine prediction:candidate · noneconsensus · none
2
citations
affunlabeled
Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) Following Blinatumomab-Induced Remission in Pediatric Patients with Relapsed/Refractory (r/r) B-Precursor Acute Lymphoblastic Leukemia (ALL): Preliminary Results from a Phase I/II Stud
Rupert Handgretinger, Lia Gore, Gerhard Zugmaier, Franco Locatelli, C. Michel Zwaan, Deepa Bhojwani +14 more
2015· article· en· Biology of Blood and Marrow Transplantation· Medicine
machine prediction:candidate · noneconsensus · none
1
citations

How this was built: Screen · Findings · About